FDA asks why Novartis took two months to launch formal internal probe, after AveXis flagged data manipulation

FDA asks why Novartis took two months to launch formal internal probe, after AveXis flagged data manipulation

Source: 
Endpoints
snippet: 

And the plot thickens. Novartis $NVS officials are reportedly now scrambling to explain to the FDA why it took them two months to open an internal investigation into data discrepancies for their $2.1 million gene-therapy for spinal muscular dystrophy — the world’s most expensive drug.